Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial barrier function
- Molecular classification
- Other (physiological barrier), Tight junction proteins, Mucins, Antimicrobial peptides, Immune receptors
01
Overview
The "bacterial barrier function" refers to a complex physiological property of epithelial barriers (especially the intestinal mucosa) that restricts the translocation of bacteria and their products from the lumen into tissue or systemic circulation. This function is mediated by a combination of mechanical (tight junctions between epithelial cells), chemical (mucus layer and antimicrobial peptides), immunological (gut-associated lymphoid tissue, immune effector cells), and biological (commensal microbial flora) components. Disruption of this barrier can result in increased susceptibility to infection and inflammatory diseases.
- Other names
- Intestinal barrier functionGut barrierMucosal barrier
02
Mechanism of action
Not applicable as a direct molecular target; modulatory mechanisms include enhancement of tight junctions, induction of mucin production, and modulation via microbial metabolites.
03
Biological functions
Prevention of bacterial translocationImmune defense (physical and chemical barrier to pathogens)Regulation of selective permeability (absorption of nutrients, exclusion of pathogens)Maintenance of gut homeostasis
04
Disease associations
Infection (compromised barrier promotes infection and sepsis)Inflammation (contributes to pathogenesis in IBD, colitis, etc.)Systemic inflammatory responseMetabolic diseases (linked to obesity, diabetes via gut permeability changes)
05
Safety considerations
Interventions that disrupt the barrier may lead to sepsis, systemic inflammation, and increased risk of infectionTherapies aiming to "boost" barrier function need to avoid excessive suppression of necessary immune responses
06
Biomarkers
Increased circulating bacterial products (e.g., endotoxin/LPS)Decreased expression of tight junction proteinsElevated intestinal permeability assays (like lactulose/mannitol ratio)
Beyond the preview
Go deeper on Bacterial barrier function.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bacterial barrier function.